JOHN ALLISON: Open Payments
NPI 1831651835 · WAYNESBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$268 in 16 payments from 6 companies in 2025. Trend: 2023 $633 · 2024 $537 · 2025 $268
Food & beverage: $268
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $72 |
| Amgen Inc. | 5 | $71 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| PFIZER INC. | 2 | $38 |
| Lilly USA, LLC | 1 | $16 |
| Organon LLC | 1 | $9 |
Products named: OTEZLA, TRELEGY ELLIPTA, PREVNAR 20, Wegovy, Ozempic, MOUNJARO, NEXPLANON.
Industry payments across PA — which companies pay providers there.
